Cross-Market Price Comparison
| Other Listed Market | Shenzhen (SZSE) — 海普瑞 |
|---|---|
| Other Market Stock Code | 002399 |
| H-Share Offer Price | HK$ 18.40 |
| Other Market Price | Loading... |
| Reference Exchange Rate | Loading... |
| H-Share Offer Price Premium/Discount vs Other Market | Loading... |
Company Overview
| Stock Name | Hepalink |
|---|---|
| Stock Code | 09989 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 我們是領先的中國製藥公司,在全球擁有製藥領域、創新生物科技領域及CDMO領域的業務。我們是最大肝素API供應商之一,亦為中國最大及全球第三大依諾肝素鈉注射液生產商及銷售商,產品組合涵蓋抗凝血及抗血栓藥物及創新候選藥物。 |
| Listing Date | 2020-07-08 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國廣東省深圳市南山區郎山路21號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | www.hepalink.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | Yes (A股) |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 18.40 / shares |
| Offer Price Range | Final offer price only, no range |
| Lot Size | 500 shares |
| Entry Threshold | HK$ 9,200 |
| Par Value | RMB 1.0 / shares |
| Offer Period | To be extracted |
| Global Offering Shares | 220,094,500 shares |
| HK Public Offer Shares (Initial) | 22,010,000 shares (10.0%) |
| Public Offer Lots (Initial) | 44,020lots (Pool A22,010lots,Pool B22,010lots) |
| International Placing Shares (Initial) | 198,084,500 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 21.0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | No |
| Total Global Offering Size | HK$ 4,049,738,800 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 500 | HK$ 9,200 |
| 2 lots | 1,000 | HK$ 18,400 |
| 3 lots | 1,500 | HK$ 27,600 |
| 4 lots | 2,000 | HK$ 36,800 |
| 5 lots | 2,500 | HK$ 46,000 |
| 6 lots | 3,000 | HK$ 55,200 |
| 7 lots | 3,500 | HK$ 64,400 |
| 8 lots | 4,000 | HK$ 73,600 |
| 9 lots | 4,500 | HK$ 82,800 |
| 10 lots | 5,000 | HK$ 92,000 |
| 12 lots | 6,000 | HK$ 110,400 |
| 14 lots | 7,000 | HK$ 128,800 |
| 16 lots | 8,000 | HK$ 147,200 |
| 18 lots | 9,000 | HK$ 165,600 |
| 20 lots | 10,000 | HK$ 184,000 |
| 30 lots | 15,000 | HK$ 276,000 |
| 40 lots | 20,000 | HK$ 368,000 |
| 50 lots | 25,000 | HK$ 460,000 |
| 60 lots | 30,000 | HK$ 552,000 |
| 70 lots | 35,000 | HK$ 644,000 |
| 80 lots | 40,000 | HK$ 736,000 |
| 90 lots | 45,000 | HK$ 828,000 |
| 100 lots | 50,000 | HK$ 920,000 |
| 120 lots | 60,000 | HK$ 1,104,000 |
| 140 lots | 70,000 | HK$ 1,288,000 |
| 160 lots | 80,000 | HK$ 1,472,000 |
| 180 lots | 90,000 | HK$ 1,656,000 |
| 200 lots | 100,000 | HK$ 1,840,000 |
| 400 lots | 200,000 | HK$ 3,680,000 |
Pool B
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 600 lots | 300,000 | HK$ 5,520,000 |
| 800 lots | 400,000 | HK$ 7,360,000 |
| 1,000 lots | 500,000 | HK$ 9,200,000 |
| 1,200 lots | 600,000 | HK$ 11,040,000 |
| 1,400 lots | 700,000 | HK$ 12,880,000 |
| 1,600 lots | 800,000 | HK$ 14,720,000 |
| 1,800 lots | 900,000 | HK$ 16,560,000 |
| 2,000 lots | 1,000,000 | HK$ 18,400,000 |
| 4,000 lots | 2,000,000 | HK$ 36,800,000 |
| 6,000 lots | 3,000,000 | HK$ 55,200,000 |
| 8,000 lots | 4,000,000 | HK$ 73,600,000 |
| 10,000 lots | 5,000,000 | HK$ 92,000,000 |
| 12,000 lots | 6,000,000 | HK$ 110,400,000 |
| 14,000 lots | 7,000,000 | HK$ 128,800,000 |
| 16,000 lots | 8,000,000 | HK$ 147,200,000 |
| 18,000 lots | 9,000,000 | HK$ 165,600,000 |
| 20,000 lots | 10,000,000 | HK$ 184,000,000 |
| 22,010 lots | 11,005,000 | HK$ 202,492,000 |
Stock Connect Inclusion Analysis
| HK Market Cap | HK$ 986.3M |
|---|---|
| Analysis Result | Already included in Stock Connect (both) |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
| First Day Close | HK$ 17.66 |
|---|---|
| First Day Open | HK$ 18.46 |
| First Day Change | -4.02% |
| First Day Volume | 103317000.0 |
| First Day Turnover | 1873060000.0 |
| Use of Proceeds | 1、約30.0%或約1,141.7百萬港元,用于改善資本結構及償還現有債務;
2、約30.0%或約1,141.7百萬港元,用于我們在歐盟及其他全球市場(如中國)拓展銷售及營銷網絡以及基礎設施;
3、約20.0%或約761.1百萬港元,用于提升我們的開發及生產能力,并擴大我們向賽灣生物提供的產品及服務;
4、約20.0%或約761.1百萬港元,用于創新藥的投資。 |
Underwriting Syndicate
Overall Coordinators (3)
Joint Bookrunners (8)
Joint Lead Managers (9)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 3W Funds | 77,454,800 HKD | — | 1.91% | — | 6 months | 2021-01-08 |
| 2 | Anlan Funds | 38,722,800 HKD | — | 0.96% | — | 6 months | 2021-01-08 |
| 3 | AVICT Global Holdings Limited | 232,382,800 HKD | — | 5.74% | — | 6 months | 2021-01-08 |
| 4 | OrbiMed Funds | 387,310,800 HKD | — | 9.56% | — | 6 months | 2021-01-08 |
| 5 | 欧万达基金管理有限公司 | 116,186,800 HKD | — | 2.87% | — | 6 months | 2021-01-08 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 李鋰 | — |
| Company Secretary | 錢風奇;陳詩婷 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 李鋰(60.12%) |
|---|




